imiquimod has been researched along with Recrudescence in 71 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (2.82) | 18.7374 |
1990's | 9 (12.68) | 18.2507 |
2000's | 35 (49.30) | 29.6817 |
2010's | 21 (29.58) | 24.3611 |
2020's | 4 (5.63) | 2.80 |
Authors | Studies |
---|---|
Aromataris, EC; Greenwood, JE; Klotz, T; Munn, Z | 1 |
Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M | 1 |
Chen, Y; Dai, Z; Han, L; Huang, RY; Liang, CL; Liu, H; Lu, C; Qiu, F; Yan, Y; Zhang, Q | 1 |
Enomoto, T; Nishijima, K; Sugai, S | 1 |
DeAngelis, F; Greenwald, Z; Rampakakis, E; Rodier, C; Steben, M; Stutz, M; Thomas, R | 1 |
Cavezza, S; Liu, X; Mounsey, K; Ni, G; Pan, X; Wang, T; Yuan, J | 1 |
Clotet, B; García-Cuyás, F; Ornelas, A; Piñol, M; Revollo, B; Sirera, G; Vela, S; Videla, S | 1 |
Guevara-Gutiérrez, E; Hernández-Torres, M; Ledesma, GS; Ruiz-González, JF; Tlacuilo-Parra, A | 1 |
Bennett, K; Copas, AJ; Doré, CJ; Gilson, R; Haddow, LJ; Jit, M; Lacey, C; Meadows, J; Murray, ML; Nathan, M; Soldan, K; Tetlow, M | 1 |
Kimura, M; Oshitani, Y; Seishima, M; Tawada, C | 1 |
Goodpasture, M | 1 |
Kofler, H; Kofler, L; Nagele, U | 1 |
Bielsa Marsol, I | 1 |
Baumgartner-Nielsen, J; Lorentzen, H | 1 |
Berrios, R; Hutchens, KA; Millsop, JW; Trinh, N; Tung, R; Winterfield, L | 1 |
Goldstone, SE; Silvera, RJ; Smith, CK; Swedish, KA | 1 |
Cavicchini, S; Chimenti, S; Javor, S; Parodi, A; Patrizi, A; Pellacani, G; Rongioletti, F; Sala, R; Stingeni, L | 1 |
Cao, W; Ge, L; Li, W; Song, H; Xin, H | 1 |
Bagot, M; Battistella, M; Cavelier-Balloy, B; Duron, JB; Gorj, M; Hickman, G; Masson, V; May, P; Petit, A; Schneider, P; Vanhaecke, C; Vilmer, C | 1 |
Angel-Müller, E; Gaitán, HG; Grillo-Ardila, CF; Lethaby, A; Ruiz-Parra, AI; Salazar-Díaz, LC | 1 |
Chang, CH; Wu, CY | 1 |
Lee, NH; Roh, SG; Shin, JY; Yang, KM; Yun, SK | 1 |
Baguley, S; Delaney, E | 1 |
Ulrich, C | 1 |
Berman, B; Harrison-Balestra, C; Perez, OA; Ramirez, C; Viera, M; Villa, A; Zell, D | 1 |
Alessi, SS; Festa Neto, C; Messina, MC; Oliveira, WR; Pimentel, ER; Sanches, JA | 1 |
Armstrong, SJ; Bath-Hextall, FJ; Ozolins, M; Williams, HC | 1 |
Bai, S; Chen, MK; Liao, QM; Ma, CG; Yang, SC | 1 |
Gilardino, MS; Lee, J; Sinno, H; Tahiri, Y | 1 |
Chan, RK; Chan, YC; Ng, KY | 1 |
Conant, M; Schacker, TW; Smith, M; Stanczak, T; Thoming, C; Wang, Z | 1 |
Berman, B; Kaufman, J | 1 |
Carrasco, D; Tyring, SK; vander Straten, M | 1 |
Eul, A; Hagedorn, M; Hopfenmüller, W; Hoyme, UB; Schindler, AE; Schneede, P; Schorn, K | 1 |
Laffitte, E; Saurat, JH | 1 |
Atzori, L; Ferreli, C; Pinna, AL | 1 |
Benson, E | 1 |
Brady, S; Wilson, JD | 1 |
Cox, JT; Petry, KU; Roy, M; Rylander, E | 1 |
Benninghoff, B; Burg, G; Dummer, R; Hafner, J; Laine, E; Maier, T; Oberholzer, PA; Slade, H; Urosevic, M | 1 |
Brown, VL; Harwood, CA; Leigh, IM; McGregor, JM; Perrett, CM; Proby, CM | 1 |
Arora, SS; Bernstein, DI; Meng, TC; Schroeder, JL; Spruance, SL | 1 |
Aractingi, S; Decuypère, L; Moyse, D; Vexiau, D | 1 |
Busquets, AC; Martin-García, RF | 1 |
Ezzell, TI; Fromowitz, JS; Ramos-Caro, FA | 1 |
Martinez, V; Molina, JM; Morfin, F; Ribaud, P; Scieux, C | 1 |
Goihman-Yahr, M | 1 |
Goldenberg, G; Jorizzo, JL; Krowchuk, DP | 1 |
Neumaier, J | 1 |
Amjad, I; Chandawarkar, RY; Deckers, PJ; Piorkowski, J | 1 |
Dinehart, S; Fielder, S; Fox, TL; Jorizzo, J; Lee, JH; Ling, M; Matheson, R; McRae, S; Moore, JK | 1 |
Bernstein, DI; Harrison, CJ; Miller, RL | 2 |
Baker, D; Edwards, L; Eron, L; Ferenczy, A; Fox, TL; Hougham, AJ; Owens, ML; Schmitt, KA | 1 |
Beutner, KR; Douglas, JM; Fox, TL; Hougham, AJ; Owens, ML; Schmitt, KA; Spruance, S; Trofatter, KF; Tyring, SK | 1 |
Ahmad, SA; Ahmad, SH; Ahmadpour, OA; Syed, TA | 1 |
Edwards, L | 1 |
Maw, RD | 1 |
Christensen, B; Hengge, UR | 1 |
Allen, AL; Siegfried, EC | 1 |
Fagnani, F | 1 |
Buckley, R; Liota , E; Menon, P; Skelton, H; Smith, KJ | 1 |
Steinhorst, M | 1 |
Benninghoff, B; Christophers, E; Meyer, T; Stockfleth, E | 1 |
Aractingi, S; Aranda, C; Garland, SM; Maw, RD; Petersen, CS; Sellors, JW; Wikstrom, A | 1 |
Bernstein, DI; Harrison, CJ; Miller, RL; Tomai, MA | 1 |
Buck, HW; Fortier, M; Knudsen, J; Paavonen, J | 1 |
Berman, B | 1 |
Bernstein, DI; Harrison, CJ; Stanberry, LR | 1 |
Bernstein, DI; Harrison, CJ; Jenski, L; Voychehovski, T | 1 |
Bernstein, DI; Harrison, CJ | 1 |
16 review(s) available for imiquimod and Recrudescence
Article | Year |
---|---|
Imiquimod to prevent keloid recurrence postexcision: A systematic review and meta-analysis.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Dermatologic Surgical Procedures; Humans; Imiquimod; Keloid; Postoperative Care; Recurrence; Secondary Prevention | 2020 |
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms | 2021 |
Management of Condyloma Acuminata in Pregnancy: A Review.
Topics: Condylomata Acuminata; Female; Humans; Imiquimod; Papillomaviridae; Photochemotherapy; Pregnancy; Recurrence | 2021 |
Genital warts treatment: Beyond imiquimod.
Topics: Administration, Topical; Anus Diseases; Catechin; Condylomata Acuminata; Drug Therapy, Combination; Humans; Imiquimod; Interferon Inducers; Interleukin-10; Papillomaviridae; Recurrence; Treatment Outcome | 2018 |
Update on the classification and treatment of localized scleroderma.
Topics: Algorithms; Aminoquinolines; Clinical Trials as Topic; Eosinophilia; Fasciitis; Glucocorticoids; Humans; Imiquimod; Immunosuppressive Agents; Methotrexate; Photochemotherapy; Physical Therapy Modalities; Recurrence; Scleroderma, Localized; Severity of Illness Index | 2013 |
Imiquimod for anogenital warts in non-immunocompromised adults.
Topics: Adult; Aminoquinolines; Anus Diseases; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Immunocompetence; Interferon Inducers; Keratolytic Agents; Male; Podophyllin; Podophyllotoxin; Randomized Controlled Trials as Topic; Recurrence; Self Administration; Warts | 2014 |
Efficacy of 2 Representative Topical Agents to Prevent Keloid Recurrence After Surgical Excision.
Topics: Administration, Cutaneous; Aminoquinolines; Dermatologic Agents; Humans; Imiquimod; Keloid; Mitomycin; Recurrence; Treatment Outcome | 2017 |
[Genital warts].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Imiquimod; Keratolytic Agents; Male; Medical History Taking; Ointments; Podophyllotoxin; Recurrence; Time Factors; Treatment Outcome; Young Adult | 2009 |
Topical treatment of field cancerization.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Organ Transplantation; Photochemotherapy; Recurrence; Skin Neoplasms; Tissue Distribution | 2009 |
Treatment options for cutaneous pyogenic granulomas: a review.
Topics: Aminoquinolines; Anti-Infective Agents, Local; Antineoplastic Agents; Cautery; Cryotherapy; Curettage; Granuloma, Pyogenic; Humans; Imiquimod; Laser Therapy; Recurrence; Sclerotherapy; Silver Nitrate; Skin Diseases | 2011 |
Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Recurrence; Retrospective Studies; Time Factors | 2002 |
Using imiquimod for genital warts in female patients.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Papillomaviridae; Quality of Life; Recurrence; Risk Factors; Viral Load; Vulvar Neoplasms; Women's Health | 2004 |
Treatment of anogenital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites; Caustics; Condylomata Acuminata; Cryosurgery; Electrosurgery; Humans; Imiquimod; Immunity, Cellular; Immunologic Factors; Immunotherapy; Interferon Inducers; Keratolytic Agents; Laser Therapy; Recurrence; Treatment Failure; Treatment Outcome | 1998 |
What's new in human papillomavirus infection.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Child; Cidofovir; Cimetidine; Cytosine; Histamine H2 Antagonists; Humans; Hypnosis; Imiquimod; Keratolytic Agents; Organophosphonates; Organophosphorus Compounds; Papillomaviridae; Podophyllotoxin; Recurrence; Risk Factors; Warts | 2000 |
[Medico-economic analysis of therapy of external condylomata acuminata].
Topics: Adjuvants, Immunologic; Aminoquinolines; Condylomata Acuminata; Drug Evaluation; Humans; Imiquimod; Interferon Inducers; Keratolytic Agents; Laser Therapy; Podophyllotoxin; Randomized Controlled Trials as Topic; Recurrence | 2000 |
Immunomodulation as a treatment strategy for genital herpes: review of the evidence.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imidazoles; Imiquimod; Recurrence | 2002 |
14 trial(s) available for imiquimod and Recrudescence
Article | Year |
---|---|
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurr
Topics: Adult; Drug Therapy, Combination; Female; Host-Pathogen Interactions; Humans; Imiquimod; Male; Papillomaviridae; Papillomavirus Infections; Papillomavirus Vaccines; Podophyllotoxin; Recurrence; Treatment Outcome; Vaccination | 2018 |
Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Double-Blind Method; Drug Administration Schedule; Humans; Imiquimod; Keloid; Middle Aged; Pilot Projects; Postoperative Complications; Prospective Studies; Recurrence; Treatment Outcome | 2009 |
The SINS trial: a randomised controlled trial of excisional surgery versus imiquimod 5% cream for nodular and superficial basal cell carcinoma.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cost-Benefit Analysis; Drug Costs; Female; Genotype; Health Care Costs; Humans; Imiquimod; Male; Ointments; Patient Satisfaction; Phenotype; Polymorphism, Genetic; Prospective Studies; Recurrence; Research Design; Skin Neoplasms; Time Factors; Treatment Outcome | 2010 |
Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Double-Blind Method; Female; Herpes Genitalis; Humans; Imiquimod; Male; Middle Aged; Recurrence; Treatment Outcome | 2002 |
Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aminoquinolines; Combined Modality Therapy; Condylomata Acuminata; Female; Humans; Imiquimod; Laser Therapy; Male; Middle Aged; Patient Compliance; Patient Dropouts; Prospective Studies; Recurrence; Treatment Outcome | 2002 |
Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals.
Topics: Administration, Cutaneous; Adolescent; Adult; Aminoquinolines; Antiviral Agents; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunocompromised Host; Interferon Inducers; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Self Administration; Treatment Outcome; Warts | 2005 |
Evaluation of imiquimod 5% cream to modify the natural history of herpes labialis: a pilot study.
Topics: Administration, Topical; Adult; Aminoquinolines; Female; Herpes Labialis; Humans; Imiquimod; Interferon Inducers; Male; Middle Aged; Pilot Projects; Recurrence; Time Factors | 2005 |
[Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation].
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aminoquinolines; Condylomata Acuminata; Dose-Response Relationship, Drug; Female; Humans; Imiquimod; Male; Middle Aged; Recurrence; Treatment Outcome | 2005 |
Combined immunotherapy of recalcitrant warts.
Topics: Administration, Cutaneous; Aminoquinolines; Dinitrochlorobenzene; Drug Administration Schedule; Drug Therapy, Combination; Foot Dermatoses; Hand Dermatoses; Humans; Imiquimod; Immunotherapy; Recurrence; Warts | 2006 |
Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.
Topics: Adult; Aminoquinolines; Double-Blind Method; Drug Administration Schedule; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis; Male; Ointments; Photosensitivity Disorders; Recurrence; Scalp Dermatoses; Treatment Outcome | 2007 |
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Adult; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Dermatitis; Double-Blind Method; Drug Administration Schedule; Erythema; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Incidence; Interferon Inducers; Male; Ointments; Pharmaceutical Vehicles; Placebos; Recurrence; Remission Induction; Safety; Self Administration; Treatment Outcome | 1998 |
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Male; Papillomaviridae; Recurrence | 1998 |
Management of female genital warts with an analog of imiquimod 2% in cream: a randomized, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Ointments; Papillomaviridae; Papillomavirus Infections; Placebos; Recurrence; Remission Induction; Tumor Virus Infections; Vulvar Diseases | 1998 |
Imiquimod 5% cream is a safe and effective self-applied treatment for anogenital warts--results of an open-label, multicentre Phase IIIB trial.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Anti-Infective Agents; Condylomata Acuminata; Consumer Product Safety; Demography; Female; Follow-Up Studies; Health Personnel; Humans; Imiquimod; Male; Middle Aged; Recurrence; Self Administration; Surveys and Questionnaires; Treatment Outcome; Vaginal Creams, Foams, and Jellies | 2001 |
41 other study(ies) available for imiquimod and Recrudescence
Article | Year |
---|---|
Dihydroartemisinin ameliorates psoriatic skin inflammation and its relapse by diminishing CD8
Topics: Animals; Artemisinins; CD8-Positive T-Lymphocytes; Disease Models, Animal; Drug Evaluation, Preclinical; Humans; Imiquimod; Immunologic Memory; Interleukin-15; Interleukin-17; Male; Methotrexate; Mice; Psoriasis; Recurrence; Secondary Prevention; Skin; Skin Transplantation; Transplantation Chimera | 2020 |
Recurrence of Human Papillomavirus External Genital Wart Infection Among High-Risk Adults in Montréal, Canada.
Topics: Administration, Topical; Adult; Aminoquinolines; Canada; Condylomata Acuminata; Cryotherapy; Female; Health Knowledge, Attitudes, Practice; Human papillomavirus 6; Humans; Imiquimod; Male; Papillomavirus Infections; Prevalence; Recurrence; Retrospective Studies; Unsafe Sex; Young Adult | 2017 |
Effectiveness of physically ablative and pharmacological treatments for anal condyloma in HIV-infected men.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Retroviral Agents; Anus Diseases; Condylomata Acuminata; Electrosurgery; Genotype; HIV Infections; Homosexuality, Male; Human papillomavirus 11; Human papillomavirus 6; Humans; Imiquimod; Infrared Rays; Male; Recurrence; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
[Riesgo de recurrencia y de nuevas neoplasias cutáneas malignas en sujetos mexicanos con carcinoma basocelular].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Electrocoagulation; Female; Humans; Imiquimod; Male; Margins of Excision; Middle Aged; Mohs Surgery; Neoplasms, Second Primary; Recurrence; Retrospective Studies; Risk; Skin Neoplasms; Young Adult | 2018 |
Successful treatment of anal and perianal condyloma acuminata with imiquimod.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anus Diseases; Condylomata Acuminata; Humans; Imiquimod; Male; Recurrence; Young Adult | 2014 |
A 4-year-old girl who presents with repeated episodes of vaginal bleeding found to have anogenital warts.
Topics: Aminoquinolines; Child Abuse, Sexual; Child, Preschool; Condylomata Acuminata; Diagnosis, Differential; Female; Hemorrhage; Humans; Imiquimod; Recurrence; Vaginal Diseases | 2013 |
Recurrent vulvovaginal candidiasis: successful suppression with imiquimod.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Candidiasis, Vulvovaginal; Female; Humans; Imiquimod; Papillomavirus Infections; Recurrence | 2013 |
Imiquimod 5%: a successful treatment for pseudolymphoma.
Topics: Administration, Topical; Aminoquinolines; Humans; Imiquimod; Immunologic Factors; Male; Middle Aged; Pseudolymphoma; Recurrence; Skin Diseases; Treatment Outcome | 2014 |
Resolution of recalcitrant pyogenic granuloma with laser, corticosteroid, and timolol therapy.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Aminoquinolines; Anti-Bacterial Agents; Biopsy; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Therapy, Combination; Granuloma, Pyogenic; Humans; Imiquimod; Laser Therapy; Lasers, Dye; Lasers, Solid-State; Male; Recurrence; Scalp Dermatoses; Timolol; Triamcinolone Acetonide | 2014 |
Anal condyloma treatment and recurrence in HIV-negative men who have sex with men.
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Anus Diseases; Chemotherapy, Adjuvant; Condylomata Acuminata; Disease-Free Survival; Electrocoagulation; HIV Seronegativity; Homosexuality, Male; Humans; Imiquimod; Lasers, Gas; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Young Adult | 2014 |
Relapsed actinic keratosis evaluation: an observational Italian multicenter prospective study. Does gender have a role?
Topics: Adult; Aged; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cohort Studies; Cryotherapy; Curettage; Diclofenac; Female; Humans; Hyaluronic Acid; Imiquimod; Italy; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Prospective Studies; Protective Clothing; Recurrence; Remission Induction; Sex Factors; Sunscreening Agents | 2014 |
Induction of vitiligo after imiquimod treatment of condylomata acuminata.
Topics: Administration, Topical; Adult; Aminoquinolines; Condylomata Acuminata; Humans; Imiquimod; Male; Recurrence; Vitiligo | 2014 |
Plantar keloids: diagnostic and therapeutic issues in six patients.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Biopsy; Colchicine; Dermatologic Surgical Procedures; Drug Administration Routes; Female; Follow-Up Studies; Foot Dermatoses; Foot Orthoses; Glucocorticoids; Gout Suppressants; Humans; Imiquimod; Keloid; Keratolytic Agents; Magnetic Resonance Imaging; Male; Recurrence; Retrospective Studies; Treatment Outcome; Triamcinolone | 2015 |
Treating recalcitrant verruca vulgaris in a pediatric patient with H2 blocker: An easy alternative approach.
Topics: Aminoquinolines; Child; Cryotherapy; Female; Histamine H2 Antagonists; Humans; Imiquimod; Ranitidine; Recurrence; Warts | 2016 |
Treatment of cutaneous tumors with topical 5% imiquimod cream.
Topics: Adjuvants, Immunologic; Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Brazil; Child; Female; Humans; Imiquimod; Male; Middle Aged; Recurrence; Retrospective Studies; Skin Neoplasms; Young Adult | 2009 |
Successful treatment of recurrent and refractory cervical condylomata acuminata with topical 5% imiquimod cream in five patients.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Cervix Uteri; Condylomata Acuminata; Female; Genital Diseases, Female; Humans; Imiquimod; Recurrence | 2010 |
The epidemiology and treatment of anogenital warts in Singapore: a retrospective evaluation.
Topics: Adolescent; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Condylomata Acuminata; Cost-Benefit Analysis; Cryosurgery; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Keratolytic Agents; Male; Middle Aged; Outcome Assessment, Health Care; Podophyllin; Recurrence; Retrospective Studies; Singapore | 2002 |
Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Ear, External; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Keloid; Male; Middle Aged; Pilot Projects; Postoperative Care; Recurrence; Time Factors | 2002 |
[Recurrent Bowen's disease of the nail: treatment by topical imiquimod (Aldara)].
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Bowen's Disease; Female; Humans; Imiquimod; Nail Diseases; Recurrence; Skin Neoplasms; Treatment Outcome | 2003 |
Extensive and recalcitrant verrucae vulgares of the great toe treated with imiquimod 5% cream.
Topics: Administration, Cutaneous; Adult; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Foot Dermatoses; Humans; Imiquimod; Male; Recurrence; Toes; Warts | 2003 |
Imiquimod: potential risk of an immunostimulant.
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Drug Antagonism; Female; Humans; Imiquimod; Immunosuppressive Agents; Papillomaviridae; Papillomavirus Infections; Recurrence; Skin Diseases; Spondylitis; Uterine Cervical Dysplasia; Vulvar Diseases; Warts | 2004 |
Closing the feedback loop: an audit of the use of imiquimod for the treatment of genital warts.
Topics: Aminoquinolines; Biopsy, Needle; Condylomata Acuminata; Dose-Response Relationship, Drug; Drug Administration Schedule; Feedback; Female; Follow-Up Studies; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Immunohistochemistry; Incidence; Interferon Inducers; Male; Medical Audit; Recurrence; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Treatment Outcome; United Kingdom | 2004 |
Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?
Topics: Adjuvants, Immunologic; Aminoquinolines; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Basal Cell; Cell Line, Tumor; Cell Survival; Disease-Free Survival; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Imiquimod; Immunoblotting; Immunohistochemistry; Interferon-alpha; Membrane Glycoproteins; Multigene Family; Oligonucleotide Array Sequence Analysis; Receptors, Cell Surface; Receptors, Opioid; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; Toll-Like Receptor 7; Toll-Like Receptors; Treatment Outcome; Up-Regulation | 2004 |
Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study.
Topics: Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Ear Diseases; Ear, External; Female; Humans; Imiquimod; Keloid; Male; Pilot Projects; Recurrence; Treatment Outcome | 2005 |
Recurrent pyogenic granuloma treated with topical imiquimod.
Topics: Administration, Topical; Aminoquinolines; Angiogenesis Inhibitors; Fingers; Granuloma, Pyogenic; Humans; Imiquimod; Male; Middle Aged; Recurrence; Skin Diseases; Treatment Outcome | 2006 |
Topical imiquimod for recurrent acyclovir-resistant HSV infection.
Topics: Adjuvants, Immunologic; Administration, Topical; Adult; Aminoquinolines; Drug Resistance, Viral; Herpes Simplex; Humans; Imiquimod; Male; Recurrence; Simplexvirus; Treatment Outcome | 2006 |
Successful treatment of a therapy-resistant pyogenic granuloma with topical imiquimod 5% cream.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Fingers; Granuloma, Pyogenic; Humans; Imiquimod; Male; Middle Aged; Recurrence; Skin Diseases | 2006 |
[Often they heal spontaneously and the treatments are not always harmless: concerning warts waiting and seeing is a legitimate therapy].
Topics: Adjuvants, Immunologic; Adult; Aged; Aminoquinolines; Child; Cryotherapy; Diagnosis, Differential; Female; Humans; Imiquimod; Immunotherapy; Keratolytic Agents; Laser Therapy; Male; Recurrence; Risk Factors; Time Factors; Warts | 2006 |
Combination therapy of a large, recurrent keloid.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Cicatrix, Hypertrophic; Combined Modality Therapy; Graft Survival; Humans; Imiquimod; Keloid; Male; Neck; Occlusive Dressings; Recurrence; Skin Transplantation | 2007 |
Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs.
Topics: Acute Disease; Aminoquinolines; Analysis of Variance; Animals; Antibodies, Viral; Drug Synergism; Female; Guinea Pigs; Herpes Simplex; Imiquimod; Interferon Inducers; Random Allocation; Recurrence; Simplexvirus; Vagina; Viral Envelope Proteins; Viral Vaccines; Virus Replication; Virus Shedding | 1993 |
Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development.
Topics: Acute Disease; Acyclovir; Aminoquinolines; Animals; Drug Synergism; Drug Therapy, Combination; Female; Ganglia, Spinal; Guinea Pigs; Herpes Genitalis; Imiquimod; Interferon Inducers; Recurrence; Spinal Cord; Vagina; Virus Shedding | 1993 |
Imiquimod in clinical practice.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Condylomata Acuminata; Double-Blind Method; Drug Administration Schedule; Female; Humans; Imiquimod; Interferon Inducers; Interferon-alpha; Male; Pharmaceutical Vehicles; Randomized Controlled Trials as Topic; Recurrence; Remission Induction | 1998 |
Recurrent urogenital herpes simplex--successful treatment with imiquimod?
Topics: Adult; Aminoquinolines; Female; Herpes Genitalis; Humans; Imiquimod; Interferon Inducers; Recurrence | 1999 |
Imiquimod therapy for molluscum contagiosum.
Topics: Adjuvants, Immunologic; Adult; Age Factors; AIDS-Related Opportunistic Infections; Aminoquinolines; Child; Drug Evaluation; Female; Follow-Up Studies; Humans; Imiquimod; Interferon Inducers; Male; Molluscum Contagiosum; Ointments; Recurrence; Sex Factors; Time Factors | 2000 |
[Proven and promising for the future].
Topics: Aminoquinolines; Anus Diseases; Clinical Trials as Topic; Condylomata Acuminata; Female; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Ointments; Recurrence; Time Factors | 2001 |
Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Recurrence; Scalp Dermatoses; Skin Neoplasms | 2001 |
Imiquimod 5% cream in the treatment of anogenital warts in female patients.
Topics: Adult; Aminoquinolines; Condylomata Acuminata; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Ointments; Recurrence; Treatment Outcome; Vaginal Creams, Foams, and Jellies | 2002 |
Imiquimod: a new immune response modifier for the treatment of external genital warts and other diseases in dermatology.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Follow-Up Studies; Humans; Imiquimod; Immunity, Innate; Keloid; Molluscum Contagiosum; Molluscum contagiosum virus; Papillomaviridae; Papillomavirus Infections; Pilot Projects; Recurrence; Warts | 2002 |
Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antiviral Agents; Female; Guinea Pigs; Herpes Genitalis; Imiquimod; Interferon Type I; Interleukin-2; Recurrence; Simplexvirus; Ultraviolet Rays; Virus Activation | 1991 |
Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection.
Topics: Administration, Intravaginal; Aminoquinolines; Animals; Antibodies, Viral; Antibody-Dependent Cell Cytotoxicity; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Herpes Genitalis; Imiquimod; Immunity, Cellular; Interferons; Interleukin-2; Lymphocyte Activation; Neutrophils; Random Allocation; Recurrence; Simplexvirus; Vagina; Virus Replication | 1988 |
Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antibody Formation; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Herpes Simplex; Imiquimod; Interferons; Nervous System Diseases; Rabbits; Recurrence; Time Factors | 1989 |